Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Impinj Stock (NASDAQ: PI) News Today: What Drove the December 24, 2025 Move—and What Analysts Forecast Next

Impinj Stock (NASDAQ: PI) News Today: What Drove the December 24, 2025 Move—and What Analysts Forecast Next

Impinj, Inc. (NASDAQ: PI) headed into the Christmas Eve session with investors debating a familiar small-cap tech paradox: a company positioned at the intersection of supply chains and “internet of things” (IoT) growth, trading at valuation levels that demand near-flawless execution. On December 24, 2025, Impinj shares finished the shortened U.S. trading day up about 3%, ending around $177–$178 per share, depending on data source. StockAnalysis+1 In a market session that typically runs thin on both liquidity and conviction, the price action still matters—because it reflects what’s currently “working” in the market narrative around RFID adoption, profitability trajectory, and the
ICL Group Ltd Stock Rises on China Potash Contracts as Bartek Deal and Dead Sea Policy Risks Shape the 2026 Outlook (NYSE: ICL)

ICL Group Ltd Stock Rises on China Potash Contracts as Bartek Deal and Dead Sea Policy Risks Shape the 2026 Outlook (NYSE: ICL)

Dec. 24, 2025 — ICL Group Ltd (NYSE: ICL) stock traded higher on Wednesday, with shares last changing hands around $5.35, up roughly 3.3% on the day as investors digested a cluster of late-December headlines spanning potash pricing visibility in China, a new food-ingredients acquisition, and evolving regulatory and legal developments tied to the company’s strategically critical Dead Sea operations. ICL sits at an unusual crossroads for a public company: part global fertilizer supplier, part specialty chemicals and ingredients platform, and part “geopolitics-meets-natural-resources” story because of its long-standing mineral concession at the Dead Sea. That blend is exactly why the
Nike Stock News (NKE) on Dec. 24, 2025: Tim Cook’s Insider Buy Sparks Rally as Wall Street Reassesses the Turnaround

Nike Stock News (NKE) on Dec. 24, 2025: Tim Cook’s Insider Buy Sparks Rally as Wall Street Reassesses the Turnaround

NIKE, Inc. (NYSE: NKE) stock is getting a rare pre-Christmas pop. In the holiday-shortened session on December 24, 2025, Nike shares climbed to around $60, up roughly 5% on the day, after regulatory filings showed a notable vote of confidence from inside the boardroom: Apple CEO Tim Cook bought nearly $3 million worth of Nike shares on the open market. Reuters+1 That headline is doing what headlines do: moving price. But for investors trying to decide whether this is the start of a sturdier rebound—or just a one-day “Santa rally” sugar rush—the more important question is what this insider buying
Shinhan Financial Group Co., Ltd. Stock (055550.KS / NYSE: SHG) Rises on Dec. 24, 2025: What Today’s News, Dividend Signals, and Analyst Forecasts Say

Shinhan Financial Group Co., Ltd. Stock (055550.KS / NYSE: SHG) Rises on Dec. 24, 2025: What Today’s News, Dividend Signals, and Analyst Forecasts Say

SEOUL / NEW YORK — December 24, 2025 — Shinhan Financial Group Co., Ltd. stock is ending the year with a familiar mix of catalysts: solid earnings power, steady capital returns, and headline risk from its credit-card unit. On Wednesday, the Korea-listed shares (KRX: 055550) finished higher even as the broader market slipped, while the U.S.-listed ADR (NYSE: SHG) traded firmly in a holiday-shortened week. Investing.com 한국어+2Korea Joongang Daily+2 Below is a full roundup of the current news, forecasts, and market analysis relevant as of Dec. 24, 2025, and what they could mean for Shinhan Financial Group stock into early
Advance Auto Parts Stock (NYSE: AAP) on Dec. 24, 2025: Latest News, Turnaround Forecasts, and Analyst Outlook

Advance Auto Parts Stock (NYSE: AAP) on Dec. 24, 2025: Latest News, Turnaround Forecasts, and Analyst Outlook

Dec. 24, 2025 — Advance Auto Parts, Inc. (NYSE: AAP) is back in focus heading into the holiday period after a volatile December for auto-parts retailers. Shares traded around $40–$41 on Dec. 24, bouncing from recent weakness as investors weigh the company’s turnaround execution, sector-wide pricing concerns, and a string of Wall Street notes. Even after today’s rebound, AAP is still moving inside a wide 52-week range of roughly $28.89 to $70.00, a reminder that the market remains deeply split on whether Advance Auto Parts is in a durable recovery—or just enjoying temporary relief rallies. MarketWatch+1 AAP stock today: where
Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology, Inc. (NASDAQ: MU) is closing out Christmas Eve trading in full “Santa rally” fashion. In the holiday-shortened U.S. session on December 24, 2025, Micron climbed to a record high and helped lift broader market sentiment as investors continued to reprice the company around one big theme: AI data centers are turning memory into the new choke point. Reuters By mid-day, MU was trading around the mid-$280s after pushing up near $289 intraday, extending the post-earnings surge that began last week. Benzinga+1 What changed isn’t that Micron “discovered AI” overnight—it’s that the company’s latest results and forward guidance arrived
POSCO Holdings Inc Stock (005490, PKX): LFP Cathode JV, US Expansion, and Fresh 2026 Analyst Forecasts on Dec. 24, 2025

POSCO Holdings Inc Stock (005490, PKX): LFP Cathode JV, US Expansion, and Fresh 2026 Analyst Forecasts on Dec. 24, 2025

December 24, 2025 — POSCO Holdings Inc. is ending the year with a familiar identity crisis—in a good way for investors. It’s still a steel heavyweight, but more and more of the market narrative is about battery materials, lithium resource security, and “green steel” pathways that could reshape earnings power over the next few years. On Dec. 24, 2025, POSCO Holdings’ Korea-listed shares closed at KRW 314,000 (+3.29%) as attention returned to the group’s “second engine”: energy and battery materials. Investing.com What changed today isn’t a single line item in a quarterly report. It’s momentum—driven by a concrete project announcement
Zeta Global (ZETA) Stock Surges on Dec. 24, 2025: Holiday Trading Spike, Analyst Targets, and the Marigold Growth Story

Zeta Global (ZETA) Stock Surges on Dec. 24, 2025: Holiday Trading Spike, Analyst Targets, and the Marigold Growth Story

Zeta Global Holdings Corp. (NYSE: ZETA) shares climbed sharply in the Christmas Eve session, extending a late-December rebound as investors continued to price in the company’s expanded 2025–2026 outlook following its Marigold enterprise acquisition and a run of “beat-and-raise” execution. As of roughly midday New York time on December 24, 2025, ZETA traded near $19.15, up about 4.36% on the day after opening at $19.01, with an intraday range of roughly $18.36 to $19.39 on about 4.0 million shares of volume. The move is landing in a shortened U.S. trading session—a detail that matters more than most people think. Both
Almonty Industries Inc. Stock (ALM) News and Forecasts on Dec. 24, 2025: Sangdong Mining Milestone, $129M Financing, and Analyst Targets for 2026

Almonty Industries Inc. Stock (ALM) News and Forecasts on Dec. 24, 2025: Sangdong Mining Milestone, $129M Financing, and Analyst Targets for 2026

December 24, 2025 — Almonty Industries Inc. has become one of the more closely watched “critical minerals” names on U.S. markets as investors try to price a rare combination: a Western-aligned tungsten supply story, a major mine transitioning from development into operations, and a fresh round of growth capital that management says fully funds its current expansion plans. On Dec. 24, 2025, Almonty’s Nasdaq-listed shares (NASDAQ: ALM) traded around the mid-$9 range during the session. MarketBeat Below is a full roundup of the current stock-moving news, forecasts, and market analysis available as of 24.12.2025, including the latest company releases, capital-markets
Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025

Zai Lab Limited (ZLAB) Stock Surges After China Approves COBENFY for Schizophrenia: News, Forecasts, and Analyst Outlook on Dec. 24, 2025

December 24, 2025 — Zai Lab Limited (NASDAQ: ZLAB, HKEX: 9688) is back in the spotlight after a major regulatory catalyst in China helped lift sentiment around the biopharma name. The company announced that China’s National Medical Products Administration (NMPA) approved COBENFY (xanomeline and trospium chloride) for schizophrenia in adults—a decision that quickly rippled into trading on both its U.S. ADR and Hong Kong listings. Business Wire+1 As of Dec. 24, 2025, Zai Lab’s U.S.-listed ADR was trading around $18.54 intraday (open $18.39, high $19.01), as risk-on buyers reacted to the approval headline and the company’s broader “pipeline-to-commercial” story. MarketBeat
Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences Ltd. (NASDAQ: WVE) is ending 2025 as one of biotech’s most watched “story stocks”—the kind that can go from sleepy to screaming in a single premarket headline, then spend weeks digesting what just happened. On December 24, 2025, Wave shares traded in the high teens (around ~$18), still hovering near the re-rated levels that followed its early obesity readout and a sizable capital raise earlier this month. Multiple market data sources showed WVE around $18.1–$18.5 intraday, with the day’s range roughly $17.49 to ~$18.5. StockAnalysis+2Investing.com Australia+2 Below is a consolidated, publication-ready look at the most relevant WVE
Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics, Inc. (NASDAQ: TVTX) is ending 2025 with a bang. In the holiday-shortened U.S. trading session on Wednesday, December 24, 2025, TVTX surged sharply—pushing to fresh highs as investors recalibrated around two big themes: accelerating commercial execution for FILSPARI (sparsentan) and a looming FDA decision that could expand the drug into a second major kidney disease indication. StockAnalysis+2New York Stock Exchange+2 TVTX stock action on Dec. 24, 2025: a thin-session breakout with big numbers In early trading on Dec. 24, TVTX was up roughly 15% and changing hands around the low $40 range—an outsized move for a single session,
1 544 545 546 547 548 884

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop